Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/20/2024 | $11.00 | Buy | ROTH MKM |
8-K - Ispire Technology Inc. (0001948455) (Filer)
S-8 POS - Ispire Technology Inc. (0001948455) (Filer)
10-Q - Ispire Technology Inc. (0001948455) (Filer)
Seeks Authorization for Pioneering Point-of-Use Identity and Age Verification Technology to Reduce Youth Access and Expand the Adult Market for Reduced-Risk Vapor Products LOS ANGELES, Nov. 18, 2024 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ:ISPR), a trailblazer in vaping technology and precision dosing, and IKE Tech LLC ("IKE Tech"), a joint venture among three leading technology and research companies Ispire, Touch Point Worldwide d/b/a Berify and Chemular Inc., announced a successful in person pre-PMTA (Pre-Market Tobacco Product Application) submission meeting with FDA's Center for Tobacco Products (CTP) for their Age Verification technology, designed to a
Gross Profit Increased 13.2% Year-Over-Year to $7.7 Million Gross Margins increased to 19.5%, up from 16.0% in Fiscal Q1 2024 Expanded Global Reach through 5-Year Master Distributor Agreement with ANDS for MENA and Global Duty-Free Markets LOS ANGELES, Nov. 11, 2024 /PRNewswire/ -- Ispire Technology Inc. (NASDAQ:ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today reported results for the fiscal first quarter 2025, which ended on September 30, 2024, and anticipates filing its annual report on Form 10-Q with the U.S. Securities and Exchange Commission (the "SEC") on November 12, 2024. Fiscal First Quarter 2025 Financial Results
In the news release, Ispire Technologies Inc. Schedules Fiscal First Quarter 2025 Earnings Conference Call, issued 07-Nov-2024 by Ispire Technology Inc. over PR Newswire, we are advised by the company that the date of the conference call should read "Monday, November 11, 2024", rather than "Tuesday, November 12, 2024", and the dial-In numbers should be "United States 844-826-3033 or International +1 412-317-5185" rather than as originally issued inadvertently. The complete, corrected release follows: Ispire Technologies Inc. Schedules Fiscal First Quarter 2025 Earnings Conference Call LOS ANGELES, Nov. 7, 2024 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ:ISPR
4 - Ispire Technology Inc. (0001948455) (Issuer)
4 - Ispire Technology Inc. (0001948455) (Issuer)
4 - Ispire Technology Inc. (0001948455) (Issuer)
Gross Profit Increased 13.2% Year-Over-Year to $7.7 Million Gross Margins increased to 19.5%, up from 16.0% in Fiscal Q1 2024 Expanded Global Reach through 5-Year Master Distributor Agreement with ANDS for MENA and Global Duty-Free Markets LOS ANGELES, Nov. 11, 2024 /PRNewswire/ -- Ispire Technology Inc. (NASDAQ:ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today reported results for the fiscal first quarter 2025, which ended on September 30, 2024, and anticipates filing its annual report on Form 10-Q with the U.S. Securities and Exchange Commission (the "SEC") on November 12, 2024. Fiscal First Quarter 2025 Financial Results
In the news release, Ispire Technologies Inc. Schedules Fiscal First Quarter 2025 Earnings Conference Call, issued 07-Nov-2024 by Ispire Technology Inc. over PR Newswire, we are advised by the company that the date of the conference call should read "Monday, November 11, 2024", rather than "Tuesday, November 12, 2024", and the dial-In numbers should be "United States 844-826-3033 or International +1 412-317-5185" rather than as originally issued inadvertently. The complete, corrected release follows: Ispire Technologies Inc. Schedules Fiscal First Quarter 2025 Earnings Conference Call LOS ANGELES, Nov. 7, 2024 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ:ISPR
LOS ANGELES, Nov. 7, 2024 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ:ISPR), an innovator in vaping technology and precision dosing, announced today that it will host its earnings conference call at 8:00am ET on Tuesday, November 12, 2024, to discuss the Company's financial results for its fiscal first quarter ended September 30, 2024. To attend the conference call, please dial in using the information below. When prompted upon dialing-in, please ask for the "Ispire Technology Call." Date: Tuesday, November 12, 2024Time: 8:00am ETDial-In Numbers: United States 866-250-8117 or International +1 412-317-6011This conference call will be broadcast live on the Inter
ROTH MKM initiated coverage of Ispire Technology with a rating of Buy and set a new price target of $11.00
LOS ANGELES, Aug. 14, 2023 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or "the Company") (NASDAQ:ISPR), a leader in vapor technology, providing high-quality, innovative products with first-class performance, announced today the appointment of Michael Wang as its Co-Chief Executive Officer. Mr. Wang previously served as Chief Financial Officer. Concurrently, Daniel J. Machock was appointed as the new Chief Financial Officer. Mr. Wang has assumed the role of Co-Chief Executive Officer alongside Tuanfang Liu, as Co-Chief Executive Officer. This strengthened leadership structure is designed to refine Ispire's strategic direction and spearhead the Company's future growth. Ispire's decision
SC 13G - Ispire Technology Inc. (0001948455) (Subject)
Roth MKM analyst Scott Fortune reiterates Ispire Technology (NASDAQ:ISPR) with a Buy and raises the price target from $11 to $12.5.
“Vaping will become the number one way for using cannabis within the next 2 or 3 years,” stated Michael Wang, CEO of Ispire Technology Inc. (NASDAQ:ISPR), during a recent interview on Benzinga’s Cannabis Insider podcast. Wang’s prediction emphasizes the advancements and growing consumer preference for vaping over traditional cannabis consumption methods. Ispire’s Rapid Rise In Cannabis Vaping Ispire, the only Nasdaq-listed American vaping company, has been a significant player since introducing the first commercially available e-cigarette in 2009. "We came to the cannabis sector about three and a half years ago and quickly became one of the top four players," Wang said, underscoring th
Roth MKM analyst Scott Fortune reiterates Ispire Technology (NASDAQ:ISPR) with a Buy and maintains $11 price target.